Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy
- PMID: 10086389
- DOI: 10.1038/6543
Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy
Abstract
Enteroviruses such as Coxsackievirus B3 can cause dilated cardiomyopathy, but the mechanism of this pathology is unknown. Mutations in cytoskeletal proteins such as dystrophin cause hereditary dilated cardiomyopathy, but it is unclear if similar mechanisms underlie acquired forms of heart failure. We demonstrate here that purified Coxsackievirus protease 2A cleaves dystrophin in vitro as predicted by computer analysis. Dystrophin is also cleaved during Coxsackievirus infection of cultured myocytes and in infected mouse hearts, leading to impaired dystrophin function. In vivo, dystrophin and the dystrophin-associated glycoproteins alpha-sarcoglycan and beta-dystroglycan are morphologically disrupted in infected myocytes. We suggest a molecular mechanism through which enteroviral infection contributes to the pathogenesis of acquired forms of dilated cardiomyopathy.
Comment in
-
Etiologies of cardiomyopathy and heart failure.Nat Med. 1999 Mar;5(3):266-7. doi: 10.1038/6474. Nat Med. 1999. PMID: 10086375 No abstract available.
Similar articles
-
Dystrophin disruption in enterovirus-induced myocarditis and dilated cardiomyopathy: from bench to bedside.Med Microbiol Immunol. 2004 May;193(2-3):121-6. doi: 10.1007/s00430-003-0189-7. Epub 2003 Aug 12. Med Microbiol Immunol. 2004. PMID: 12920582
-
Dissociation of sarcoglycans and the dystrophin carboxyl terminus from the sarcolemma in enteroviral cardiomyopathy.Circ Res. 2000 Sep 15;87(6):489-95. doi: 10.1161/01.res.87.6.489. Circ Res. 2000. PMID: 10988241
-
Inhibition of Coxsackievirus-associated dystrophin cleavage prevents cardiomyopathy.J Clin Invest. 2013 Dec;123(12):5146-51. doi: 10.1172/JCI66271. Epub 2013 Nov 8. J Clin Invest. 2013. PMID: 24200690 Free PMC article.
-
Enteroviral cardiomyopathy: bad news for the dystrophin-glycoprotein complex.Herz. 2000 May;25(3):227-32. doi: 10.1007/s000590050011. Herz. 2000. PMID: 10904843 Review.
-
Sarcoglycans in muscular dystrophy.Microsc Res Tech. 2000 Feb 1-15;48(3-4):167-80. doi: 10.1002/(SICI)1097-0029(20000201/15)48:3/4<167::AID-JEMT5>3.0.CO;2-T. Microsc Res Tech. 2000. PMID: 10679964 Review.
Cited by
-
Viral myocarditis and dilated cardiomyopathy: mechanisms, manifestations, and management.Postgrad Med J. 2001 Jan;77(903):4-10. doi: 10.1136/pmj.77.903.4. Postgrad Med J. 2001. PMID: 11123385 Free PMC article. Review.
-
Cardiovascular Complications of Neuromuscular Disorders.Curr Treat Options Cardiovasc Med. 2002 Apr;4(2):171-179. doi: 10.1007/s11936-002-0037-x. Curr Treat Options Cardiovasc Med. 2002. PMID: 11858779
-
Myofibrillar remodeling in cardiac hypertrophy, heart failure and cardiomyopathies.Can J Cardiol. 2006 Sep;22(11):953-68. doi: 10.1016/s0828-282x(06)70315-4. Can J Cardiol. 2006. PMID: 16971981 Free PMC article. Review.
-
Characteristics of Electrocardiogram Findings in Fulminant Myocarditis.J Cardiovasc Dev Dis. 2023 Jun 30;10(7):280. doi: 10.3390/jcdd10070280. J Cardiovasc Dev Dis. 2023. PMID: 37504536 Free PMC article.
-
IL-21R expression on CD8+ T cells promotes CD8+ T cell activation in coxsackievirus B3 induced myocarditis.Exp Mol Pathol. 2012 Jun;92(3):327-33. doi: 10.1016/j.yexmp.2012.03.009. Epub 2012 Mar 21. Exp Mol Pathol. 2012. PMID: 22465422 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous